Clinical trials
Observational Hepatitis C trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Completed | 5 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 2 |
| The First Hospital of Jilin University | 2 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Bristol-Myers Squibb | 1 |
| Hong Ren | 1 |
| Huashan Hospital | 1 |
| Johnson & Johnson Medical, China | 1 |
| Junqi Niu | 1 |
| National Taiwan University Hospital | 1 |
| Singlera Genomics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 14 |
| Hepatitis | 2 |
| Hepatitis B | 2 |
| Carcinoma, Hepatocellular | 1 |
| Coinfection | 1 |
| Hepatitis C, Chronic | 1 |
| Liver Cirrhosis | 1 |
| Liver Diseases | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.